Induction Heal. Regulatory News (INHC)

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

Purchase of Shares by Directors

Induction Healthcare (AIM: INHC), a leading flexible care company, announces the following Director purchases of, in aggregate, 130,000 ordinary share in the Company:

Andy Williams, Non-Executive Director, purchased 100,000 Ordinary Shares at a price of 48 pence per ordinary share. As a result of this transaction, Andy Williams' total shareholding in the Company comprises 519,495 Ordinary Shares, representing approximately 0.56 per cent. of the Company's issued share capital.

Hugo Stephenson, Group Executive Director, purchased 30,000 Ordinary Shares at a price of 48 pence per ordinary share. As a result of this transaction, Hugo Stephenson's total shareholding in the Company comprises 2,126,273 Ordinary Shares, representing approximately 2.31 per cent. of the Company's issued share capital. This excludes the 7,152,600 Ordinary Shares which are held by Blue Muse Investments Pty Ltd, as trustee of The Blue Muse Trust (a trust which is controlled by Hugo Stephenson's mother and of which close relatives including his children and friends of Hugo Stephenson are beneficiaries).

ENQUIRIES

About Induction -  www.inductionhealthcare.com

Induction (AIM: INHC) is a leading flexible care platform driving digital transformation of healthcare systems worldwide. Induction solutions enhance the investments hospitals have made and lay the foundation for their future. Our products can enable information sharing between busy doctors, alleviate operational burdens on hospitals or put patients in better control of their care, all while ensuring the highest standards of clinical safety and information security. We unchain staff and patients from the limitations of paper-based and desktop systems, creating substantial time and cost efficiencies.

More than 225,000 hospital doctors across multiple territories, including the UK, Ireland, Australia and South Africa, as well as a rapidly growing number of more than 300,000 UK patients, choose Induction solutions.

Induction Switch is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting.

Induction Guidance provides medical organisations, including most hospital trusts within the NHS, with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. This increases knowledge of, and adherence to, guidance.

Induction Zesty is a market-leading digital platform for patients visiting hospitals. The platform allows patients to book and access their appointments, read their clinical letters, store a copy of their clinical record and provide data to their care teams remotely. It is not just a compelling patient experience, but also delivers significant cost benefits to hospitals.

Induction Attend Anywhere is the UK market leader in secondary care video consultations. It helps hospitals, health systems and other customers offer video consultations to patients and service users as a normal part of day-to-day clinical activity. Our vision is for video consultations to improve lives and help address social, access, equity and sustainability challenges by allowing healthcare providers to determine how and when they see a patient based on each individual case: in-person, via video or on the telephone.

Induction HealthStream is a proprietary data integration platform that reads and writes patient demographic, appointment and clinical record data between a growing number of hospital EHR systems and the Induction platforms. This connectivity between stakeholders and legacy IT systems adds substantial value to pre-existing health IT investment and allows large-scale adoption of Induction app-based services.